Welcome to our dedicated page for Mannatech news (Ticker: MTEX), a resource for investors and traders seeking the latest updates and insights on Mannatech stock.
Mannatech Incorporated (MTEX) provides science-backed wellness solutions through nutritional supplements and skincare products across global markets. This page serves as the definitive source for official company announcements and market-relevant developments.
Investors and industry observers will find curated press releases covering financial results, product innovations, regulatory updates, and leadership changes. All content is maintained to reflect MTEX's position in the competitive wellness sector and its direct-to-consumer business model.
Key updates include earnings reports, research advancements in natural health formulations, and strategic partnerships. Regular monitoring of this resource enables stakeholders to track operational milestones and market expansion efforts across the Americas, EMEA, and Asia/Pacific regions.
Bookmark this page for streamlined access to MTEX's evolving corporate narrative. Combine these primary sources with broader market data for informed analysis of this wellness industry innovator.
Mannatech (NASDAQ: MTEX) announced its Q1 2024 financial results, reporting an EPS of $0.63 compared to $0.32 in Q1 2023. Net sales decreased by 13.8% to $29.4 million, primarily due to weak economic conditions in the Asia/Pacific region and reduced recruitment of sales associates and preferred customers. Gross profit margin increased to 78.6%, with operating income rising slightly to $0.8 million. Net income was $1.2 million, up from $0.6 million in Q1 2023. The company saw a 2.3% increase in cash and cash equivalents, reaching $7.9 million. Despite economic challenges, Mannatech aims to boost revenues by expanding its sales network while maintaining cost controls.